Overview
This study aims to evaluate the possible nephroprotective effect of nicorandil in patients with type 2 diabetes mellitus .
Eligibility
Inclusion Criteria:
- Patients newly diagnosed with T2DM with diet control and good glycemic index ( Hb A1C< 7 )
- Age range between 18 and 60 years old.
- Both sexes.
- Stage 1and Stage 2 CKD according to KDIGO .
- Controlled HTN .
Exclusion Criteria:
- Pregnant and lactating females.
- Patients with hypersensitivity to nicorandil.
- Other Causes of CKD or Nephropathy eg : Uncontrolled HTN , Renal Malignancy , collagen disease as Amyloidosis and some autoimmune disease as ( SLE and Rh.fever ) .
- Uncontrolled HTN and its antihypertensive medications ( ACEI , ARB ) and other antihypertensive medications .
- Patients receiving nephrotoxic drugs as aminoglycosides, non-steroidal anti inflammatory drugs and contrast media.